Ifeatu Uchenna Oti, MD - Medicare Nephrology in Tyler, TX

Ifeatu Uchenna Oti, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Tyler, Texas. She graduated from medical school in 1999 and has 25 years of diverse experience with area of expertise as Nephrology. She is a member of the group practice Etmc Physician Group, Inc., Tyler Nephrology Associates Pa and her current practice location is 1133 Medical Dr, Tyler, Texas. You can reach out to her office (for appointments etc.) via phone at (903) 595-5486.

Ifeatu Uchenna Oti is licensed to practice in Texas (license number N5305) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1003087388.

Contact Information

Ifeatu Uchenna Oti, MD
1133 Medical Dr,
Tyler, TX 75701-2130
(903) 595-5486
(903) 595-5128



Physician's Profile

Full NameIfeatu Uchenna Oti
GenderFemale
SpecialityNephrology
Experience25 Years
Location1133 Medical Dr, Tyler, Texas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Ifeatu Uchenna Oti graduated from medical school in 1999
  NPI Data:
  • NPI Number: 1003087388
  • Provider Enumeration Date: 03/14/2008
  • Last Update Date: 05/04/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3577596071
  • Enrollment ID: I20100319000792

Medical Identifiers

Medical identifiers for Ifeatu Uchenna Oti such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003087388NPI-NPPES
2108011-01MedicaidTX
200280780 AMedicaidOK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 34742 (Oklahoma)Secondary
207RN0300XInternal Medicine - Nephrology 7363 (South Dakota)Secondary
207RN0300XInternal Medicine - Nephrology 35.086016 (Ohio)Secondary
207RN0300XInternal Medicine - Nephrology N5305 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Rcg Mineola DialysisMineola, TXDialysis facility
Fresenius Medical Care Tyler Home DialysisTyler, TXDialysis facility
Christus Mother Frances HospitalTyler, TXHospital
Ut Health East Texas Tyler Regional HospitalTyler, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Etmc Physician Group, Inc.4486915600276
Tyler Nephrology Associates Pa690186224224

News Archive

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line data from its open-label phase IIIb trial evaluating XIAFLEX for the treatment of adult Dupuytren's contracture patients with multiple palpable cords. The Company enrolled 60 patients at eight sites throughout the U.S. and Australia.

Missouri GOP state senators poised to nix Medicaid expansion

In addition, reports offer insights into how the debate over the health law's Medicaid expansion is playing out in Tennessee and Ohio.

Watson seeks FDA approval to market rasagiline mesylate tablets

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.

Also in global health news: U.S. global development policy; DDT in Uganda; potential drought, famine in Ethiopia

"President Barack Obama has signed a Presidential Study Directive [PSD] authorizing a U.S. government-wide review of global development policy, according to sources briefed on the review by the White House," Foreign Policy's blog, "The Cable," reports. The new PSD is important, according to people in development, "because it signals the intent to reach across government agencies to think through a more coordinated and strategic approach to development policy," according to the blog (Rozen, 8/31).

New symbiotic starter culture investigated for production of original yogurt

Yogurt production is traditional branch in our food industry. Yogurt is a fermented milk product that contains the characteristic bacterial cultures Lactobacillus bulgaricus and Streptococcus thermophilus. One of them is invented and used for the first time in our country and that's why it is named after Bulgaria.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ifeatu Uchenna Oti allows following entities to bill medicare on her behalf.
Entity NameTyler Nephrology Associates Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942360326
PECOS PAC ID: 6901862242
Enrollment ID: O20041208000236

News Archive

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line data from its open-label phase IIIb trial evaluating XIAFLEX for the treatment of adult Dupuytren's contracture patients with multiple palpable cords. The Company enrolled 60 patients at eight sites throughout the U.S. and Australia.

Missouri GOP state senators poised to nix Medicaid expansion

In addition, reports offer insights into how the debate over the health law's Medicaid expansion is playing out in Tennessee and Ohio.

Watson seeks FDA approval to market rasagiline mesylate tablets

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.

Also in global health news: U.S. global development policy; DDT in Uganda; potential drought, famine in Ethiopia

"President Barack Obama has signed a Presidential Study Directive [PSD] authorizing a U.S. government-wide review of global development policy, according to sources briefed on the review by the White House," Foreign Policy's blog, "The Cable," reports. The new PSD is important, according to people in development, "because it signals the intent to reach across government agencies to think through a more coordinated and strategic approach to development policy," according to the blog (Rozen, 8/31).

New symbiotic starter culture investigated for production of original yogurt

Yogurt production is traditional branch in our food industry. Yogurt is a fermented milk product that contains the characteristic bacterial cultures Lactobacillus bulgaricus and Streptococcus thermophilus. One of them is invented and used for the first time in our country and that's why it is named after Bulgaria.

Read more Medical News

› Verified 2 days ago

Entity NameEtmc Physician Group, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609382662
PECOS PAC ID: 4486915600
Enrollment ID: O20180305002106

News Archive

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line data from its open-label phase IIIb trial evaluating XIAFLEX for the treatment of adult Dupuytren's contracture patients with multiple palpable cords. The Company enrolled 60 patients at eight sites throughout the U.S. and Australia.

Missouri GOP state senators poised to nix Medicaid expansion

In addition, reports offer insights into how the debate over the health law's Medicaid expansion is playing out in Tennessee and Ohio.

Watson seeks FDA approval to market rasagiline mesylate tablets

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.

Also in global health news: U.S. global development policy; DDT in Uganda; potential drought, famine in Ethiopia

"President Barack Obama has signed a Presidential Study Directive [PSD] authorizing a U.S. government-wide review of global development policy, according to sources briefed on the review by the White House," Foreign Policy's blog, "The Cable," reports. The new PSD is important, according to people in development, "because it signals the intent to reach across government agencies to think through a more coordinated and strategic approach to development policy," according to the blog (Rozen, 8/31).

New symbiotic starter culture investigated for production of original yogurt

Yogurt production is traditional branch in our food industry. Yogurt is a fermented milk product that contains the characteristic bacterial cultures Lactobacillus bulgaricus and Streptococcus thermophilus. One of them is invented and used for the first time in our country and that's why it is named after Bulgaria.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ifeatu Uchenna Oti is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ifeatu Uchenna Oti, MD
1133 Medical Dr,
Tyler, TX 75701-2130

Ph: (903) 595-5486
Ifeatu Uchenna Oti, MD
1133 Medical Dr,
Tyler, TX 75701-2130

Ph: (903) 595-5486

News Archive

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line data from its open-label phase IIIb trial evaluating XIAFLEX for the treatment of adult Dupuytren's contracture patients with multiple palpable cords. The Company enrolled 60 patients at eight sites throughout the U.S. and Australia.

Missouri GOP state senators poised to nix Medicaid expansion

In addition, reports offer insights into how the debate over the health law's Medicaid expansion is playing out in Tennessee and Ohio.

Watson seeks FDA approval to market rasagiline mesylate tablets

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.

Also in global health news: U.S. global development policy; DDT in Uganda; potential drought, famine in Ethiopia

"President Barack Obama has signed a Presidential Study Directive [PSD] authorizing a U.S. government-wide review of global development policy, according to sources briefed on the review by the White House," Foreign Policy's blog, "The Cable," reports. The new PSD is important, according to people in development, "because it signals the intent to reach across government agencies to think through a more coordinated and strategic approach to development policy," according to the blog (Rozen, 8/31).

New symbiotic starter culture investigated for production of original yogurt

Yogurt production is traditional branch in our food industry. Yogurt is a fermented milk product that contains the characteristic bacterial cultures Lactobacillus bulgaricus and Streptococcus thermophilus. One of them is invented and used for the first time in our country and that's why it is named after Bulgaria.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Tyler, TX

Preetham Reddy Muskula, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 2608 Mcdonald Rd, Tyler, TX 75701
Phone: 903-595-5514    Fax: 903-262-3715
Dr. Varalaxmi Bhavani Nannaka, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 912 S Fleishel Ave, Tyler, TX 75701
Phone: 903-592-6901    
David A Brickey, DO
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 800 E Dawson St, Tyler, TX 75701
Phone: 903-525-1914    
Randy Craig Randall, MD
Nephrology
Medicare: Medicare Enrolled
Practice Location: 1783 Troup Highway, Tyler, TX 75701
Phone: 903-595-2283    Fax: 903-595-1063
Nabeel K Ahmed, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 1133 Medical Dr, Tyler, TX 75701
Phone: 903-595-5486    Fax: 903-595-5128
Dr. Amanda Nicole Long, D.O.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 619 S Fleishel Ave, Ste 327, Tyler, TX 75701
Phone: 903-510-1173    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.